肝纤维化发生相关信号传导通路研究进展*

doi:10.3969/j.issn.1672-5069.2015.01.029

Abstract

Abstract: Hepatic fibrosis （HF） is a pathological process in a variety of chronic liver diseases, which may eventually progressed to cirrhosis or even liver cancer. Therefore,how to delay,cease or reverse HF is particularly important. HF is a complicated process that is involved by various cytokines and cell signaling pathways. Elucidation of these signaling pathways might provide some approaches to intervene the development of HF.

Key words: Liver fibrosis, Signaling pathway, Hepatic stellate cells

Li Xin, Zhu Ying. Signaling pathways in hepatic fibrosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(1): 101-104.

References

[1] 王彩生,赵志清. 肝纤维化发病机制研究进展. 内蒙古医学杂志,2010,42（3）：331-334.
[2] 黄越龙,周春光,陈燕,等. TGF/Smad信号通路与肝纤维化的研究进展. 实用医学杂志,2011,27（10）：1883-1884.
[3] 吕涛,姚希贤. TGF-β1/Smad信号传导通路与肝纤维化. 河北医科大学学报,2012,33（6）：735-740.
[4] 陈勇良,李振燕,姚春甫,等. TGF-β1、PDGF- BB与慢性乙型肝炎肝纤维化相关性研究. 实用肝脏病杂志,2010,13（2）：100-103.
[5] 徐新保,何振平,冷希圣,等. 敲除Smad4基因对小鼠肝纤维化与肝癌发生和发展的影响. 中华肝脏病杂志,2010,18（2）：119-123.
[6] 施凤,朱萱. NOX介导的MAPK、PI3K/Akt信号通路与肝纤维化的研究进展.世界华人消化杂志,2012,20（28）：2685-2690.
[7] 杨斌,曾维政,吴晓玲. HSCs表型转化的信号转导通路及其阻断剂的研究进展.世界华人消化杂志,2009,17（22）：2283-2291.
[8] 陈莲香,舒建昌. PDGF与肝纤维化关系的研究新进展. 胃肠病学和肝病学杂志,2011,20（1）：95-98.
[9] 张银枝,徐军全,康杰,等. 内毒素对大鼠原代肝星状细胞ERKl/2信号转导通路的影响. 中国医疗前沿,2012,7（3）：35-37.
[10] 周光耀,金玲湘. 瘦素、血管紧张素II对肝纤维化作用的研究进展. 中国初级卫生保健,2009,23（12）：106-107.
[11] 田卫斌,王春胜,李晓伟,等. 大鼠肝纤维化形成过程中TGF-β1/ERK信号通路与I、Ⅲ、Ⅳ型胶原表达变化. 胃肠病学和肝病学杂志,2010,19（5）：414-419.
[12] 杨清高,刘绍能. P38 MAPK信号通路与肝纤维化. 世界华人消化杂志,2012,20（24）：2231-2236.
[13] 吴文娟,杨妙芳,许小兵,等. p38MAPK在大鼠实验性肝纤维化发生中的表达及其意义. 世界华人消化杂志,2008,16（34）：3822-3827.
[14] 郑人源,蒋明德,梅浙川,等. 肝星状细胞增殖与p38丝裂原活化蛋白激酶信号传导通路的关系. 中国组织工程研究与临床康复,2011,15（20）：3711-3714.
[15] Liu J,Lin A. Role of JNK activation in apoptosis:a double-edged sword. Cell Res,2005,15（1）:36-42.
[16] 魏娜,贺海波,张长城,等. JNK信号通路与细胞凋亡关系的研究进展. 中国临床药理学与治疗学,2013,18（7）：807-812.
[17] 钟显飞,蒋明德,马洪德,等. JNK信号通路对乙醛刺激的大鼠肝星状细胞增殖的影响. 西南国防医药,2004,14（4）：350-353.
[18] Song G,Ouyang G,Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med,2005,9（1）:59-71.
[19] 徐永锋,管洪庚,薛万江,等. 磷脂酰肌醇3（PI3K）激酶信号途径对血小板源生长因子促肝星状细胞增殖与I型胶原表达的影响. 苏州大学学报,2006,26（3）：389-391.
[20] 管洪庚,徐永峰,兰晶. 血小板源生长因子通过PI3K/AKT途径促肝星状细胞增殖与I型胶原合成. 中华实验外科杂志,2007,24（11）：1332-1334.
[21] Arbouzova NI,Zeidler MP. JAK/STAT signalling in Drosophila:insights into conserved regulatory and cellular functions. Development,2006,133（14）: 2605-2616.
[22] 王晓红,曹琦,胡成穆. JAK/STAT通路调节IL-4诱导的肝星状细胞系LX-2 I型胶原基因的表达. 基础医学与临床,2012,23（4）：423-427.
[23] 牛丽文,曹琦,李俊,等. JAK/STAT途径调节瘦素诱导的肝状细胞I型胶原基因的表达. 中国药理学通报,2007,23（10）：1280-1284.
[24] 张久聪,聂青和. 核因子-κB与肝纤维化分子调控. 实用肝脏病杂志,2009,12（1）：63-66.
[25] 李伟伟,宋新文,王宏伟,等. 核转录因子-κB与肝炎肝纤维化病理分期的相关性. 中国免疫学杂志,2013,29（3）：251-254.
[26] 洪金妮,王标辉,安海燕. Rho/ROCK信号通路参与肝纤维化过程的研究. 中西医结合肝病杂志,2013,23（2）：123-125.
[27] Brown JH,Del Re DP,Sussman MA. The Rac and Rho hall of fame:a decade of hypertrophic signaling hits. Cric Res,2006, 98:730-742.
[28] 英嵩崧,李旭,张振书. 血管紧张素1-7对大鼠肝星状细胞Rho-Rock信号转导通路的影响. 现代消化及介入诊疗,2013,18（3）：145-147.
[29] 万赞燕,胡国信. Wnt信号转导通路与肝纤维化关系的研究现况. 世界华人消化杂志,2011,19（17）：1761-1766.
[30] 何益,熊伍军,刘菲. Wnt信号转导通路与肝纤维化. 国际消化病杂志,2008,28（1）：57-59.
[31] Zeng G,Awan F,Otruba W,et al. Wnt’er in liver:expression of Wnt and frizzled genes in mouse.Hepatology,2007,45（1）:195-204.
[32] 李文庭,陈西柳,李宜,等. Wnt抑制因子-1对肝星状细胞活化的影响. 肝脏,2012,15（5）：338-341.
[33] 何益,熊伍军. Wnt4/Frizzled2在肝纤维化组织中的表达及其意义. 肝脏,2008,13（3）：216-218.
[34] 沈旭,胡青婷,宋兴福. 整合素/黏着斑激酶信号通路及转化生长因子-β信号通路与肝星状细胞活化的关系. 广东医学,2013,34（9）：1460-1462.
[35] 耿建章,甄真,陈翠英,等. 整合素α5β1及黏着斑激酶在肝纤维化中的作用. 疑难病杂志,2009,8（6）：344-346.

Signaling pathways in hepatic fibrosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[2]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[3]	Zhang Ying, Wang Hongyan, Chi Cheng, et al. Cross-talk between Notch and LPS-TLR4-NF-κB inflammatory signaling pathways in LPS-activated HepG2 cells [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 470-473.
[4]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[5]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[6]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[7]	Zhou Liyun, Li Xiaotian, Li Li. 1,25（OH）₂D₃ inhibits hepatic fibrosis by regulating miR-146a levels in vitro and in vivo [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 333-336.
[8]	Jiang Yi, Liu Bing. Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
[9]	Yusup Tursun, Zhao Yanxia.. Establishment of low-dose diethylnitrosamine-induced liver fibrosis model in rats [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 33-36.
[10]	Mai Jingyin, Chen Tianyang, Ping Jian, et al.. Effects of MiR-384 on SIRT3/FOXO1 signaling pathway in HFFA-induced Hepa1-6 cells in vitro [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 829-832.
[11]	Guo Xiaoxia, Guo Beiting, Kong Xianglu.. Effects of splenectomy on hepatic fibrosis in mice with poly I:C-induced primary biliary cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 837-841.
[12]	Huang Chunming, Yang Zhan, Nie Yuqiang, et al.. Prediction of liver fibrosis by gamma-glutamyl-transpeptidase-to-platelet ratio in patients with chronic hepatitis B viral infection with normal serum transaminase levels [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 859-862.
[13]	Zheng Zhenchuan, Xu Xihai.. Pathological and clinical features and factors affecting significant liver fibrosis in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 713-716.
[14]	Ren Tao, Pan Wen, Xu Li, et al. Clinical features of liver cirrhosis in Tibetan minority [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 352-355.
[15]	Chen Hui, Ren Wanlei, Yang Aiting. Hepatic progenitor cell transplantation accelerates spontaneous reverse of hepatic fibrosis in rats with carbon tetrachloride-induced liver fibrosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 376-379.